
Music festivals have become more open to harm reduction initiatives. How far will it go?
NEW YORK — The sounds of muffled percussion and audience cheers reverberate throughout the grounds. Brand activations, makeshift bars and restaurant pop-ups control traffic as a sea of bodies move from set to set. Sandwiched between is a row of nonprofits across familiar causes: hunger, housing and voter registration.
It's a common music festival scene, until closer inspection. There is a new table, This Must Be the Place. The Ohio-based nonprofit offers attendees free opioid overdose reversal treatment and training on how to use it, an education acquired in under two minutes. Just a few years ago, their inclusion might've been unthinkable amid murky regulations and a lack of public awareness surrounding harm reduction.
Advocates say drugs are commonly consumed at music festivals, making them ideal locations for harm reduction activities. While more music festivals are allowing such activities, activists are pushing for expanded efforts as some festivals remain cautious.
Founded by William Perry and Ingela Travers-Hayward in 2022, This Must Be The Place has since given away an estimated $4.5 million in naloxone, the opioid overdose reversal medication, at festivals and smaller community events.
In the very beginning, without a 'proof of concept,' as Perry describes it, they had trouble partnering with festivals. Eventually, a few festivals in the Midwest agreed to let them table, which 'got us in the door with Bonnaroo in 2022,' says Perry, referring to the major U.S. festival operated by C3 Presents, one of the largest concert promoters on the planet. Now they have a presence at 35 major U.S. festivals — including Lollapalooza, Governors Ball and Besame Mucho — where they collaborate directly with C3 and their security personnel.
The organization's growth overlaps with advancing federal regulations. According to Daliah Heller, vice president of overdose prevention initiatives at the global public health nonprofit Vital Strategies, naloxone distribution used to be determined by state regulations until 2023, when the Food and Drug Administration approved the first over-the-counter nasal spray.
'We no longer need the prescription laws to be amended to allow for the distribution of naloxone,' she says. 'Now it's like buying aspirin — it's over the counter.'
Last year, This Must Be the Place gave away 46,146 units of Narcan — a brand name for naloxone — through their national festival outreach.
Emmett Beliveau, chief operating officer of C3 Presents, says working with This Must Be the Place was C3's first time implementing public-facing harm reduction strategies, in addition to the promoter's existing medical programs.
Bringing the organization into C3's festivals was 'not in response to anything that has happened at one of our festivals,' he says, but rather because of the 'number of fatalities happening in our communities.'
Some activists believe attendees are most responsive to receiving harm reduction education from peers instead of authority figures. And so, for the last three years, a nonprofit dedicated to combating accidental drug overdoses among young adults, Team Awareness Combating Overdose, has distributed fentanyl test strips and Narcan at the Coachella Valley Music and Arts Festival .
Former TACO CEO Kameran Mody says that music festivals are ideal locations for distribution and education because 'music and the use of drugs are synonymous with each other.'
TACO distributes through what Mody describes as 'guerrilla-style marketing.' They enlist volunteers, train them on how to use naloxone, and ship Narcan and test strips to them to bring into the festival.
They do not involve the festival organizers. Representatives for Coachella did not respond to The Associated Press' requests for comment.
In 2023, a TACO volunteer administered Narcan to an unresponsive Coachella attendee exhibiting signs of an overdose. The organization says the attendee regained consciousness.
'That was one of our biggest successes,' Mody says.
In 2019, at Bonnaroo, a 27-year-old man was found dead at his campsite — right after harm reduction activists had picketed the Tennessee festival because it didn't allow drug testing. The toxicology report found ecstasy and fentanyl in his system.
At the time, under state law, test strips were criminalized and classified as drug paraphernalia. That's changed: In 2022, Tennessee decriminalized fentanyl test strips. By the end of 2023, 44 other states and D.C. had done the same.
But in some states, drug paraphernalia laws are written in a way that isn't completely transparent — there are test strips that are not fentanyl-specific, Heller points out — and criminalization and social stigmas endure.
Some have found workarounds. 'Even in the states where the legalities were a bit unclear, instead of just coming in and hoping things worked out, we would reach out to the health department, and say 'We run this project, how do feel about it?'' says Perry. 'We would end up with letters from the highest-ranking health official, either in the county or in the state, saying 'We approve of this.' That circumvented any roadblocks.'
Some festivals, though, might be hesitant to use test strips because 'it's tough for them to admit that drugs are being used,' Mody says. Some festivals have even banned naloxone.
While This Must Be The Place distributes fentanyl test strips at some Ohio events, C3 doesn't distribute test strips at its events and does not plan to. Beliveau doesn't believe fentanyl test strips are effective and expressed concern they could encourage drug use. Test strips, which can detect fentanyl in pills, powders or injectables, are recommended by the Centers for Disease Control and Prevention as a low-cost means of helping prevent drug overdoses.
At a three-day electronic music festival in Mexico City earlier this year, a booth provided free, anonymous drug testing. The initiative, known as 'Checa tu Sustancia' (Check Your Substance), was spearheaded by the Instituto RIA, a Mexico-based drug policy research and advocacy organization.
When unexpected substances are detected, users received detailed information on what they are, their risks, potential interactions with other substances and dosage adjustments, empowering them to make informed choices.
Perry says they are aware of smaller festivals in the United States conducting drug checking, but 'they do it in a very underground and whisper network way' to avoid criminalization.
What Perry says his organization would like to see at music festivals in the future would be harm reduction areas — sections where attendees who have taken drugs can be monitored, not to 'get them into trouble' but to ensure safety.
Heller says there are a number of groups working to destigmatize drugs, promote decriminalization, and promote drug checking.
'We already have drug checking happening in cities,' she says. 'It makes perfect sense to expand the settings where you would offer that to include music festivals. It's the same rationale. ... The issue is this idea of liability. You'd have to create a law, essentially, that would protect the festival from liability.'
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


CBS News
9 minutes ago
- CBS News
Cook County jury awards $20.5 million to family of girl who died from toxic levels of morphine
A Cook County jury awarded more than $20 million in damages to the family of an 11-year-old girl who died from toxic levels of morphine. In October 2020, Ava Wilson was recovering from leukemia when she went for a follow-up appointment at Advocate Children's Hospital. During her appointment, she was crying from pain, and had difficulty walking, according to her family's attorneys. Lab tests revealed she had low platelet counts, low blood cell counts, high liver enzymes, and low blood pressure. She was discharged from Advocate Children's Hospital with instructions to take 15 milligrams of morphine every four hours, triple the amount of her previous prescriptions. A nurse practitioner also increased her gabapentin prescription. Approximately 36 hours after getting home, she died in her sleep from acute drug toxicity of several substances, including lethal levels of morphine in her system at the time of her death. Her family's attorneys said the hospital should have admitted Ava to the hospital to get her blood pressure under control and treat the cause of her pain, but simply sent her home with excessive pain medications. "Ava's body was yelling out to these clinicians, 'help me!', and they just ignored it," attorney Matthew Williams said. After a civil trial, a jury awarded her family $20.5 million in damages. "While nothing will ease the depth of Ava's loved ones' pain, the family appreciates that the jury recognized that Ava's death was preventable and that she should still be with them today," attorney Aaron Boeder said.


Medscape
11 minutes ago
- Medscape
Fast Five Quiz: Late-Onset Pompe Disease
Multiple genetic variants have been associated with LOPD. However, the c.-32-13T>G splice site variant is found in up to 90% of adults and 50% of pediatric patients. Patients with LOPD often have compound heterozygous genotypes, with one allele carrying the common c.-32-13T>G splice-site variant and the other harboring a more deleterious GAA mutation (eg, nonsense, frameshift, or large deletion). Other variants— such as and c.1935C>A — are more commonly seen in infantile forms of Pompe disease. Learn more about the pathophysiology of LOPD. Diagnosis of LOPD typically follows a two-step approach: first, measuring GAA enzyme activity (often via dried blood spot assay) followed by confirmatory molecular genetic testing to identify pathogenic GAA variants. Although once considered a first-line diagnostic tool for LOPD, muscle biopsy is no longer preferred due to its invasive nature and the non-specificity of histologic findings. Muscle biopsy may still be considered in rare, ambiguous cases when enzyme and genetic testing are inconclusive or conflicting. CK levels might be elevated in some patients but are nonspecific and primarily serve to raise clinical suspicion. Learn more about the workup for LOPD. Enzyme replacement therapy (ERT) has significantly changed the natural history of the disease by improving survival and stabilizing motor and respiratory function. However, key limitations in skeletal muscle uptake and variability in clinical response remain. This is due to low expression of the mannose-6-phosphate receptor in muscle tissue, which hampers enzyme internalization. As a result, patients might experience a limited or plateaued response. Newer approaches, including modified ERT and gene therapy, are being developed to address this issue. High toxicity to cardiac muscle, uniform patient response, and development of cardiac hypertrophy have not been reported as key limitations. Learn more about treatment options for LOPD. NBS programs have reshaped the understanding of Pompe disease, particularly LOPD. A significant proportion of screen-positive newborns harbor genetic variants associated with LOPD, including pseudo deficiency alleles and variants of uncertain significance. These individuals are often asymptomatic at birth and might not develop symptoms for years, if at all. This has raised important clinical questions around monitoring, counseling, and when (or whether) to initiate therapy; expanded screening has also revealed that the true prevalence of LOPD might be higher than historical estimates suggested. Learn more about the management of LOPD. Editor's Note: This article was created using several editorial tools, including generative AI models, as part of the process. Human review and editing of this content were performed prior to publication. Lead image: UCSF/Science Source


CNN
27 minutes ago
- CNN
Kennedy names new members of CDC vaccine advisory panel days after removing previous advisers
Vaccines Federal agencies Respiratory virusesFacebookTweetLink Follow Just two days after retiring the entirety of the US Centers for Disease Control and Prevention's vaccine advisory panel, US Health and Human Services Secretary Robert F. Kennedy Jr. has appointed several prominent critics of the government's Covid-19 response to that committee. He announced eight new members of the CDC's Advisory Committee on Immunization Practices, or ACIP, on Wednesday. Kennedy had said Monday that the previous 17-member panel that makes recommendations on who should get vaccines and when was rife with conflicts of interest and that he would appoint new 'highly credentialed' experts in time for the panel's June 25 meeting, at which the members are expected to discuss guidance for Covid-19 and HPV shots, among others. In a statement Wednesday, Kennedy said the reassembled panel will demand 'definitive safety and efficacy data before making any new vaccine recommendations, but will also review data for the current vaccine schedule as well.' The eight new ACIP members include Dr. Robert Malone, a biochemist who made early innovations in the field of messenger RNA but in more recent years has been a vocal critic of mRNA technology in Covid-19 vaccines. The CDC recently narrowed its recommendations for mRNA Covid-19 shots, but some advocates in the Make America Healthy Again space have pressed Kennedy to go further and bar the vaccines entirely. Another new member is Dr. Martin Kulldorff, a biostatistician and epidemiologist who co-authored an October 2020 strategy on herd immunity known as the Great Barrington Declaration with Dr. Jay Bhattacharya, now director of the US National Institutes of Health. Both Malone's and Kulldorff's names were circulated early in the second Trump administration as potential advisers on ACIP or other panels, according to a person familiar with the process who requested anonymity because they weren't authorized to speak with CNN. Kennedy also chose Dr. James Pagano, an emergency medicine physician he described as a 'strong advocate for evidence-based medicine' who has served on hospital committees and medical executive boards. Dr. Retsef Levi, an MIT professor who has published studies on mRNA vaccines and cardiovascular events, is also joining the panel. Levi is a professor of operations management. Several of the new members have served in federal health agencies previously, including Dr. Joseph Hibbeln, a former acting chief of the NIH's section on nutritional neurosciences. Dr. Cody Meissner, a Dartmouth professor of pediatrics who also signed the Great Barrington Declaration, has previously served on ACIP and on the US Food and Drug Administration's Vaccines and Related Biological Products Advisory Committee. Dr. Vicky Pebsworth, the Pacific region director of the National Association of Catholic Nurses, also served on the FDA committee and on a national panel reviewing the 2009 H1N1 swine flu vaccine. Dr. Michael Ross, a professor of obstetrics and gynecology at George Washington University and Virginia Commonwealth University, has previously served on the CDC's Advisory Committee for the Prevention of Breast and Cervical Cancer. Kennedy also nodded in his statement to Ross' 'continued service on biotech and healthcare boards.' The private equity company Havencrest, in which Ross is an operating partner, describes him on its site as a 'serial CEO' who has served on the boards of several biotechnology companies.